Quarterly report pursuant to Section 13 or 15(d)

Stockholders??? Equity (Details Narrative)

v3.21.2
Stockholders’ Equity (Details Narrative) - USD ($)
$ / shares in Units, $ in Thousands
9 Months Ended
Sep. 30, 2021
Dec. 31, 2020
Jun. 02, 2020
Subsidiary, Sale of Stock [Line Items]      
Sale of stock, number of shares issued 2,127,660    
Proceeds from issuance of stock $ 46,800    
Number of awards granted 121,703    
Number of awards outstanding 1,352,111 1,806,092  
Unrecognized compensation expense $ 4,800    
Compensation expense, period for recognition 2 years 3 months 18 days    
Amended and Restated 2013 Incentive Compensation Plan      
Subsidiary, Sale of Stock [Line Items]      
Shares available for issuance 743,790   1,000,000.0
Common stock reserved for issuance     2,956,250
Number of awards granted 834,060    
Number of awards outstanding 1,378,400    
Employee Stock Purchase Plan      
Subsidiary, Sale of Stock [Line Items]      
Shares available for issuance 400,000    
Public Offering      
Subsidiary, Sale of Stock [Line Items]      
Sale of stock, number of shares issued 2,127,660    
Common stock initially offered at public offering 1,850,140    
Public offering price, per share $ 23.50    
Shares sold pursuant to exercise of underwriters option 277,520    
Price per share for underwriters option to purchase $ 22.09    
Proceeds from issuance of stock $ 46,800